1:00PM – 2:00PM, January 26, 2015 – Clinical Methodologies of NGS – LIVE @Silicon Valley 2015 Personalized Medicine World Conference, Mountain View, CA
Real Time Conference Coverage with Social Media
@Computer History Museum by Dr. Aviva Lev-Ari, PhD, RN
1:00PM – 1:15PM Mike Snyder, Stanford (Chair)
Analyzing Complex Diseases Using Integrative Omics Technologies
LIVE FROM THE PODIUM
Complex Disease
- Highest prevalence: Diabetes and Autism as examples
- Personal “Omics” Profiling – Molecualr measurement: Microbiome, metabolomics via Urine
- Principles
- Genome Sequence(Illumina, Complete Genomics): Predict Diabetes
- Life Time change if the Genome sequencing find risk for diabetes
- Metabolic Disorder can be familial
- Molecules and Biochemical Pathways that change during acquisition of Diabetes: Insulin, Biosynthetic pathway
- Microbiome is important for health: implicated in IBD: Crohn’s and Enterical Colitis
- in Nasal microbes: Streptococcus pneumonie
- Stool microbiome: during fever Respiratory infection: Gut microbiome changes
- 70 Prediabetics: Personal Omics profile – data sensors:
- other data types sensors: Insulin Resistance –>>> obesity — Diabetes
- AUTISM: protein in patients –
- Cetificate in Genomics
1:15PM – 1:30PM Patrick Roche, HTG Molecular -mRNA and MiRNA
NGS-based Molecular Profiling from a Single FFPE Section
LIVE from the PODIUM
Molecular Profiling is slow: the alternative is
HTGEdge CHemistry
- Nuclease protection – HTG EdgeSeq – No DNA or RNA: extraction of RNS for adoptors like Illumina Sequencer
- HTG and NGS – Edge Chemistry is optimized for NGS workflow
- miRNA Asssay – Whole Transcriptome (HTG EdgeSeq WTA
- Reproducability Tissue microarrays (TNAs)
- Lung Fusions Assay: Measure expression of HERs microarrays
- Fusion Measurement Techniques
- Cellline carrying – Lung Fusion – HTG EdgeSeq: ALK, ROS1, RET, NTRK1 Fusion
- Analytics Software: Rearrange for 5’/3′ length
- HERs insertion
- Comprehensive Molecular Profiling: The Product
- Profile expression of 2500 cancer related genes
- Oncology Biomarker Panel:
- COmprehensive molecular profiling
1:30PM – 1:45PM Michael Ball, GenoLogics
The Impact of Informatics on Clinical NGS Services
LIVE from the PODIUM
- Informatics market is $Billion
- 23andMe
- Informatics
- Operations in multiple locations
- From Start Up to Genome Factory
- ClarityLIMS
- 8 weeks kickoff to production
- Future is in the CLOUD
- Informatics: prevention of errors
1:45PM – 2:00PM Jason Merker, Stanford University School of Medicine
Using Genome Sequencing in the Clinical Setting
LIVE from the PODIUM
- WOrlflow: Stanford CLinical Genomics Service
- MD order a test
- Genetics Counsellor counsalt
- question posed to patient and treating team
- insurance authorisation
- biobanking
- results of Illumina sequencer
- Data analysis (MedGAP)
- variants analysis
- curation meeting
- genomics Review Group
- Genomics Review Board – Bioethic/legal, additional genetics expertise
- FINAL report generation: coverage of metrics, meeting with genetic COunselor
- Multidisciplinary team – more precise clinical genetic care
- GS is a test for AUNEXPALINED GENETIC DISEASES
- potential methodology improvements
- CNV and other SV detection
2:00PM – 2:15PM John Ryals, Metabolon, Inc. CLIA
Getting More from NGS: Metabolomics as a First-line Phenotyping Tool
LIVE FROM THE PODIUM
Where knowing COmes to Life?
- Discovery HD4 platform launched in 4/2014
- 200 molecules are derived from bacterial metabolism
- Metabolon’s proprietaty technologydevelopment
- Human Metabolome Individually
- Metabolon GWAS Study- Nature 477, 54-60 (2011)
- 145 Associations
- Conclusiono: Genetic Origins of Individual Variations in Metabolosm
200 patients – blood and urine tests
70 unaffected cases
Correct Disease assessment
- Patient 11315: thymidine – Maple Syrup Urine Disease mutation on an ENZYME
- Metabolic signatures in Patients: Gzene Penetrations
- case 3905 – Fructose intollerence vs sorbitol Case 3958: Urea Case 3976: Liver – shows tylenol toxicite
Leave a Reply